Phenotypic screening in drug discovery has been revived Using the expectation of supplying promising lead compounds and drug targets and increasing the success amount of drug approval. Nonetheless, target identification remains A significant bottleneck in phenotype-primarily based drug discovery. We recognized the lead compounds K542 and K405 havin